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Interactions between the gut microbiome and the brain are of increasing interest to
both researchers and clinicians. Evidence is mounting on the causal role of an altered
gut microbiome in inflammatory diseases such as arthritis, inflammatory bowel disease,
obesity and diabetes, and psychiatric diseases like anxiety and depression. Mechanisms
include altered energy harvest from food, hormonal changes, increased gut permeability,
inflammation, immune response, and a direct influence on the brain and behavior.
Anorexia nervosa (AN) is the third most common disease in adolescence and exacts
a high burden on patients and caregivers. It often becomes chronic and has the highest
mortality of all psychiatric diseases. As AN is characterized by nutritional restrictions,
weight loss, and severe behavioral symptoms including weight phobia, comorbid anxiety
and depression, accompanied by endocrine alterations, increased inflammation, and
immune response, exploring the role of the gut microbiome is crucial. Here, we present
an overview of the potential mechanisms of interaction between the gut microbiome, the
host and particularly the brain in AN and summarize the initial findings of microbiome
research on AN. We conclude by identifying future research directions and potential
therapeutic approaches, including nutritional interventions, probiotics, prebiotics and
food supplements, that could become important additions to current AN therapy.
Keywords: anorexia nervosa,microbiome, inflammation, autoimmune disease, gut-brain axis, nutrition, probiotics,
prebiotics
INTRODUCTION
Anorexia nervosa (AN) is one of the most common chronic illnesses in adolescence, with a lifetime
prevalence of 1–4% in 12–18-year-old girls in Europe (1). Recent studies report incidence rates of
100–200/100,000 person-years in 15–19-year-old females, which is similar to that of type 1 diabetes
(2, 3). In Germany and the UK, the number of hospitalized children and adolescents has risen
substantially during the last decade (4), and the age of onset has decreased (5). After a relatively
brief window of treatment opportunity, the starvation process in AN is often self-perpetuating
(6). AN has a high risk of becoming chronic and has the highest mortality of all psychiatric
disorders (7, 8). However, in the early stages of the disorder, no indicator currently exists that
enables predicting the course and outcome of the disorder. In an 18-year follow-up study, 25%
of the subjects with previous adolescent AN were unemployed because of a mental disorder (9).
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Psychiatric and somatic comorbidity, including depression,
anxiety and starvation-induced somatic changes such
as endocrine dysfunctions and osteoporosis is high, and
therefore further impedes a favorable outcome. A multimodal
treatment approach involving weight rehabilitation and
psychotherapy is the current state-of-the-art approach, but
underlying pathophysiology and proliferating factors are not
well understood.
Evidence is now growing that AN-induced starvation is
associated with profound alterations of the gut microbiome
(10–13), which is of critical interest given its important
interactions with the host metabolism in terms of weight
regulation, hormonal, immunologic and inflammatory processes,
along with a direct influence on the brain and behavior
(“gut-brain axis”) (14–18) (see Figure 1). AN is one of the
most “exemplary” disorders for studying gut-brain interactions
because no other mental disease exists in which nutrition and
its changes, which are important factors influencing microbial
growth in the intestine, play such a crucial role (19). Based
on the DSM-5, we differentiate between two subtypes of AN,
restrictive and binge/purging. While the restrictive subtype is
characterized by fasting and often, but not always, physical
hyperactivity, patients classified as the binge/purging subtype
may engage in binging and purging (e.g., laxative abuse or
self-induced vomiting), only binging (with intermittent periods
of fasting or excessive exercising) or only purging. In an
FIGURE 1 | Interactions of the gut microbiome with the brain and behavior, in the intestinal tract and with immunology in patients with AN. ED, eating disorder [from
Seitz et al. (18)].
important study by Mack et al. (10) significant differences
in the microbiome were found between the restrictive and
the binge/purging subtypes. Moreover, we may speculate that
iatrogenic changes in the diet implicated in the treatment of AN,
and thus of the microbiome, might also impact the course of
the disorder.
Each human individual has close to 500 out of approximately
1,000 different gut microbial species (20), yielding a highly
personal composition. Many digestive functions are thought to
have been “delegated” to the gut microbiome over the course of
evolution. In this symbiotic relationship, certain gut microbes
break down food to supply the host with essential vitamins,
fatty acids and other nutrients that the host would otherwise
be unable to extract. However, the role of the gut microbiome
extends well beyond digestion: the community of microbes is
in continuous exchange with the cells of the gut wall and
beyond, informing our immune system and affecting intestinal
permeability, hormones and inflammation (15). Mechanisms
involved in the gut-brain axis that directly influence the brain and
behavior are not well understood, but seem to include direct vagal
nerve signaling, immune cell migration to the brain, antibodies,
cytokines and hormones (15, 21, 22). Causal roles of microbiome
alterations have been found in anxiety disorder, depression and
reactions to stress (21), all of which are important symptoms
or comorbidities of AN (1). In this review, we summarize the
pertinent findings regarding these mechanisms of interaction
Frontiers in Endocrinology | www.frontiersin.org 2 February 2019 | Volume 10 | Article 41
Seitz et al. Gut-Brain Axis in Anorexia Nervosa
between themicrobiome and the host and how they can influence
the pathophysiology and symptoms of AN.
HORMONES
AN is characterized by profound endocrine alterations (23). Gut
microbes are influenced by hormones and neurotransmitters
and in turn affect hormonal and neurotransmitter secretion.
Consistent evidence of multiple pathways of bidirectional
interaction [for a review, see Neuman et al. (15)], including
microbes producing dopamine (24), serotonin (24),
norepinephrine (25) and GABA (25), as well as insulin and blood
sugar regulation (26), has been reported. Germ free (GF) mice,
born and raised in completely sterile environments, have proven
to be valuable sources of information. Compared to normally
raised control animals, they exhibited a 25% increased TSH level
(27), but decreased plasma catecholamine (25), and serotonin
(28) levels. The satiety hormone leptin was associated with an
increased abundance of Bifidobacterium and Lactobacillus and
a decreased abundance of Bacteroides and Prevotella, while the
hunger hormone ghrelin showed inverse relationships (29).
Gut bacteria are thought to help regulate orexin release from
neuroendocrine cells which in turn influences local neural
communication in the gut as well as central nervous functions
of hunger signaling (30). Patients with AN have increased
ghrelin and orexin and reduced leptin and thyroxin levels,
so hormonal interaction with the microbiome seems likely.
Amenorrhea induced by a chronic estrogen deficit is a core
symptom of AN. Estrogen has been shown to decrease bacterial
virulence but enhance bacterial culture growth rates (24), so
further interactions with the gut microbiome can be expected.
Lastly, starvation in AN is characterized by increased serum,
urinary and salivary cortisol levels (23). GF-mice also showed
elevated corticosterone levels, indicating a stress modulating
and potentially stress reducing role of the microbiome (31).
Notably, the administration of Lactobacillus and Bifidobacteria
decreased circulating corticoid hormone levels in both humans
and rats (32), further emphasizing the causal role of the
microbiome in stress regulation, which might suggest a useful
therapeutic option.
ENERGY HARVEST/BODY WEIGHT
The microbiome plays a central role in the amount of
energy harvested from a specific quantity of food, with
important implications for body weight regulation. In 2005, it
was discovered that compared with normal weight controls,
overweight patients have an altered gut microbiome, which
appears able to extract more energy from the same food (33).
Furthermore, a causal role of the microbiome was demonstrated
when stool transplanted from obese mice into GF-mice resulted
in greater weight gain than stool from lean rodents (34). This
finding was confirmed in humans when stool transferred before
bariatric surgery caused rats to increase in fat mass, whereas stool
transferred after surgery did not (35). Stool transfer from the
malnourished child of twin children discordant for kwashiorkor
in Malawi into GF-mice induced weight loss and malnutrition
(36). Additionally, oral antibiotics measurably ameliorated the
nutritional state of children fromMalawi (37). The proportion of
Bacteroidetes was found to be a potentially important factor, as
their abundance was associated with body mass index in normal-
, under-, and overweight patients (12). Notably, Bacteroidetes
is decreased in acutely ill patients with AN and increased upon
weight recovery (10, 11, 38). Mack et al. also showed a significant
difference of the microbiome between the binge-purging and
the restrictive subtypes of AN (10). Differences in the microbial
species that extract energy from the same quantity of food could
help explain why patients with the restrictive subtype require
dramatically more calories to gain weight compared to patients
with the binge-purging subtype (39).
INTESTINAL PERMEABILITY
Elevated stress and cortisol levels increase gut permeability,
increasing the number of digestion components traversing the
gut wall barrier and entering intra- and extra-cellular spaces in
the host (40). However, whether higher cortisol levels in patients
with AN also cause increased gut permeability is currently being
researched. Mörkl et al. (41) could not provide evidence of an
increased intestinal permeability in an initial study in patients
with AN using blood zonulin levels, and Monteleone et al. (42)
found reduced permeability in the small intestine by studying
lactulose/mannitol absorption. However, Jesus et al. (43) showed
a “leaky gut” in the colon, including fewer tight junction proteins,
reduced gastric wall thickness and increased colonic permeability
using the Activity-Based Anorexia mouse model. Achamrah et
al. (44) also found increased colonic permeability using FITC-
Dextran in the same AN animal model, and our own animal
research may further support these initial findings, showing
reduced cryptal depth and decreased tight junction proteins in
the colon of rats, but not in the small intestine (manuscript in
preparation). The gut microbiome interacts with the intestinal
wall and strongly influences its permeability and barrier function
(45). Themicrobiome in patients with AN appears to shift toward
an increase of mucin-degrading Firmicutes and Verrucomicrobia
and away from the carbohydrate-degrading species Bacteroidetes
(10, 11) (see below). This shift could increase digestion of
the protective intestinal wall mucus and further weaken the
intestinal wall barrier in the colon, allowing greater translocation
of bacterial products and components (10, 43), which might
trigger immune and inflammatory responses (46–48).
AN—AN AUTOIMMUNE DISORDER?
In two recent meta-analyses, patients with AN showed a
low-grade inflammatory state with increased TNF-alpha, IL-
6, and IL-1-beta (49, 50). As certain Lactobacilli can reduce
TNF-alpha, IL-6, and IL-8 (51), this approach may offer an
interesting treatment option for reducing intestinal permeability
and inflammation in patients with AN. Fetissov et al. (52) found
that the translocation of bacteria and their subcomponents across
the intestinal wall can also cause cross-reactive antibodies to
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form, which can bind to hunger and satiety hormones such as
ghrelin or alpha-melanocyte stimulating hormone (alpha-MSH)
(53), thus, altering food intake and weight regulation (54, 55).
Moreover, increased levels of antibodies for a large number of
hunger and satiety hormones including leptin, ghrelin, orexin,
and alpha-MSH were found in patients with eating disorders,
including patients with AN, and some of the antibodies even
correlated with eating disorder symptom severity (54, 56). A
potential mechanism could be that these antibodies protect
these hormones from degradation, as could be evidenced for
anti-ghrelin antibodies (55, 57). Auto-antibodies could thus
be an important underlying phenomenon in AN and one
mechanism by which the gut microbiome influences the brain
and complex behaviors such as hunger and satiety (18). Notably,
patients with AN also showed a generally increased proneness to
autoimmune diseases in large Finnish and Swedish cohorts (58,
59). Specifically, the prevalence of gastrointestinal (OR 1.8) and
endocrine autoimmune diseases (OR 2.4) was higher, whereas
Crohn’s disease showed the highest rate with an OR of 3.9.
Patients with autoimmune diseases also had an increased risk
of AN (60). Anecdotally, a Crohn’s disease patient also affected
by AN reported a significant improvement in AN symptoms
after anti-TNF-alpha treatment, suggesting another link between
autoimmune diseases and AN (61).
GUT-BRAIN AXIS
The gut microbiome has a significant effect on our development
and the brain, starting at birth. Contact with different bacteria,
depending on our mode of birth, i.e., vaginally or via C-
section, and whether we were breastfed strongly influence which
bacteria inhabit our gastrointestinal tract, with probably lifelong
consequences for our immune system (62). The number of
metabolic and neurologic diseases with altered gut microbiome
and evidence for gut-brain interactions is constantly rising (63):
In type 2 diabetes the microbiome appears to disturb the enteric
nervous system via inflammatory processes, impairing its role in
informing the hypothalamus of the nutritional state to properly
control glucose entry in tissues (64, 65). In Parkinson’s disease,
α-Synuclein aggregates, the major neuropathologic marker of the
disease, are detectable in the enteric nervous system prior to
the brain, with a possible gut to brain prion-like transmission
(66); abundance of Prevotellaceae is reduced by 80%, and
abundance of Enterobacteriaceae was highly correlated with
postural instability and gait difficulty (67). Stool from depressive
patients, who often show increased inflammatory markers, was
able to evoke depressive-like symptoms when introduced into
antibiotics-treated rodents - but not the stool of healthy controls
with no mood disorder (68). In 18 children with autism,
who had a heavily altered gut microbiome, continued stool
transplants from healthy subjects normalized the microbiome,
reduced gastrointestinal symptoms by 80% and improved autistic
symptoms for at least 8 weeks after treatment ended (69).
Again, causal inferences can be made by studying GF-mice: they
exhibit deviant morphologic and functional brain development
(70) and different brain-derived neurotropic factor (BDNF)
concentrations in the blood and the hippocampus (71), which
influence neuron growth and protection as well as synapse
formation and connectivity. Notably, patients with AN also
showed reduced BDNF serum levels during semi-starvation,
which were alleviated upon weight restoration (72). Antibiotics
were shown to decrease BDNF levels in the hippocampus in GF-
animals increasing levels of anxiety and thus indicating a direct
link between the microbiome, behavior and the brain (73). This
finding was further corroborated in a study with mice in which
antibiotics were used to eradicate the gut microbiome. The result
was decreased cell neurogenesis in the hippocampus with ensuing
learning deficits, mediated by certain monocytes that could cross
the blood-brain barrier. Probiotics, the application of potentially
beneficial live bacteria (here, Bifidobacteria and Lactobacillus),
were able to reverse both deficits (22). Patients with AN have
been shown to suffer from significant brain volume loss, both in
gray and white matter (74), associated with neuropsychological
deficits and negative clinical prognosis (75). Here, our own group
could also identify underlying impaired cell neogenesis in the
AN animal model that was most strongly affecting astrocytes
(76). We also found functional memory impairments (77).
The neurotransmitter serotonin seems to be another important
mediator between the microbiome and the brain. GF-mice
showed a significantly higher level of serotonin metabolite 5-
hydroxyindoleacetic acid [5-HIAA] in the hippocampus (78).
The same metabolite was found to be reduced in the CSF of
patients with AN during the acute phase, but it increased after
weight recovery (79). The exact link between microbiota and
brain changes in AN, however, remains to be elucidated.
INITIAL FINDINGS OF AN
Initial studies analyzing altered microbiomes in patients with
AN have reported heterogeneous results (14, 16, 18, 80). Cross-
sectional studies involving between nine and 20 patients (12, 13,
38, 41, 81, 82), a longitudinal study with three patients (83) and
combined cross-sectional studies with a longitudinal follow-up of
up to 44 patients (10, 11) have been reported. Two studies found
reduced alpha diversity (measuring the number of different
species in the sample) (11, 41), whereas two others found changes
in the same direction that were not significant (10, 82). Lower
alpha diversity is commonly interpreted as disequilibrium of
the microbial community, potentially decreasing its genetic pool
and ability to react to disturbances. Reduced alpha diversity was
also observed in patients with obesity and inflammatory bowel
disease and has been correlated with heightened inflammatory
levels and intestinal permeability (84). Mack et al. (10) showed a
significant increase in alpha diversity during weight restoration,
and Kleiman et al. (11) found a trend in the same direction.
In Kleiman et al.’s cohort, alpha diversity in the starved state
was correlated with eating disorders and depressive and anxious
symptoms (11), highlighting another functional relevance of this
finding. Increased beta diversity (measuring the dissimilarity
of the microbiome between different individuals in the group)
was found for two groups (10, 11), showing an increased
variability in the AN sample. This diversity decreased after
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weight rehabilitation, but importantly, the microbiome in the
patients with AN nevertheless more closely resembled their
own microbiome before weight gain than that of the healthy
controls (10). Firmicutes increased in abundance whereas
Bacteroidetes decreased in two samples, as noted above (10,
11). The archaea Methanobrevibacter smithii increased in three
samples (10, 81, 82), while the Roseburia species decreased
in two samples (10, 82). M. smithii was inversely correlated
with body mass index in one study (81). Its presence is
typically interpreted as an adaptivemechanism to increase energy
exploitation (10). Increased protein-degrading Firmicutes, as
mentioned, could further induce mucin reduction and intestinal
permeability. Decreased Roseburia, which feeds on carbohydrates
and normally produces butyrate, could additionally increase
intestinal permeability (85) and inflammation (86) due to a
lack of the protective impact of this non-branched-chain fatty
acid. Two studies showed heightened levels of branched-chain
fatty acids. These digestive products of protein fermentation
were previously found to increase PYY-production, a gastric





Research on the interaction of the human microbiome with
its host is rapidly increasing for a variety of somatic and
mental disorders (14, 21, 46, 84). In patients with AN, we
require longitudinal observation studies that identify the
role of the gut microbiome in energy utilization, appetite,
gastrointestinal symptoms, neurocognition and learning,
depression, anxiety, and clinical outcome. To clarify the
pathophysiologic mechanisms, human and animal intervention
studies that pay careful attention to determining causality
are required. Furthermore, we must critically analyze current
refeeding practices for patients with AN. As nutrition is a crucial
influencing factor of the gut microbiome, we must question
the provision of standard hospital food to patients without
considering the patients’ prior diets. The rapid change from
typically low amounts of a fiber-rich, low-fat diet prior to
admission to a high caloric, high fat and carbohydrate diet will
affect the composition of their gut microbiome. The change from
a non-animal- to an animal-based diet can tremendously impact
the microbiome (19). However, patients who have often been on
a vegan or vegetarian diet and who require oral supplements or
nasogastric feeding typically receive cow milk-based products,
with unclear consequences on their microbiome (14, 17). Most
doctors, furthermore, do not know that 25% of all drugs (not
only antibiotics) impact the gut microbiome (88). Thus, research
on refeeding therapy for AN is urgently required to prevent
causing iatrogenic harm to our patients (14).
Future additions to traditional AN therapy aiming to
positively influence the gut microbiome could include nutritional
interventions, food supplements, probiotics and prebiotics
(dietary fibers favoring the growth of certain bacteria). The
goals could be to increase the amount of energy harvested from
the same quantity of food and to decrease gut permeability,
inflammation and antibody formation, with the potential
consequence of reducing depressive and anxious symptoms.
Preclinical research has demonstrated promising results (45),
and healthy controls have shown improved mood and cognitive
function in a recent study (89, 90). A recent systematic review
of 10 RCTs on the use of probiotics for anxiety and depression
in patients found, despite methodological limitations because of
the different bacterial strains applied, “preliminary evidence of
psychological benefits” (91).
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